These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 19353224)

  • 1. Influence of direct admission to Comprehensive Stroke Centers on the outcome of acute stroke patients treated with intravenous thrombolysis.
    Pérez de la Ossa N; Millán M; Arenillas JF; Sánchez-Ojanguren J; Palomeras E; Dorado L; Guerrero C; Dávalos A
    J Neurol; 2009 Aug; 256(8):1270-6. PubMed ID: 19353224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the stroke code activation source on the outcome of acute ischemic stroke patients.
    de la Ossa NP; Sánchez-Ojanguren J; Palomeras E; Millán M; Arenillas JF; Dorado L; Guerrero C; Abilleira S; Dávalos A
    Neurology; 2008 Apr; 70(15):1238-43. PubMed ID: 18322264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion.
    Zaidat OO; Suarez JI; Santillan C; Sunshine JL; Tarr RW; Paras VH; Selman WR; Landis DM
    Stroke; 2002 Jul; 33(7):1821-6. PubMed ID: 12105360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aphasia predicts unfavorable outcome in mild ischemic stroke patients and prompts thrombolytic treatment.
    Nesi M; Lucente G; Nencini P; Fancellu L; Inzitari D
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):204-8. PubMed ID: 23352114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct admission to stroke centers reduces treatment delay and improves clinical outcome after intravenous thrombolysis.
    Kim DH; Bae HJ; Han MK; Kim BJ; Park SS; Park TH; Lee KB; Kang K; Park JM; Ko Y; Lee SJ; Choi JC; Kim JT; Cho KH; Hong KS; Cho YJ; Kim DE; Lee J; Lee J; Oh MS; Yu KH; Lee BC; Nah HW; Cha JK
    J Clin Neurosci; 2016 May; 27():74-9. PubMed ID: 26778045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct access to a hospital offering intravenous thrombolysis therapy improves functional outcome of acute ischemic stroke patients.
    Kim DH; Cha JK; Park HS; Choi JH; Kang MJ; Huh JT
    J Clin Neurosci; 2014 Aug; 21(8):1428-32. PubMed ID: 24980628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the drip-and-ship approach to delivering thrombolysis for acute ischemic stroke safe?
    Martin-Schild S; Morales MM; Khaja AM; Barreto AD; Hallevi H; Abraham A; Sline MR; Jones E; Grotta JC; Savitz SI
    J Emerg Med; 2011 Aug; 41(2):135-41. PubMed ID: 19272734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute ischemic stroke and thrombolysis location: comparing telemedicine and stroke center treatment outcomes.
    Ionita CC; Sharma J; Janicke DM; Levy EI; Siddiqui AH; Agrawal S; Baker JG; Agopian E; Olson K; Hopkins LN
    Hosp Pract (1995); 2009 Dec; 37(1):33-9. PubMed ID: 20877169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-arterial adjuvant tirofiban after unsuccessful intra-arterial thrombolysis of acute ischemic stroke: preliminary experience in 16 patients.
    Kwon JH; Shin SH; Weon YC; Hwang JC; Baik SK
    Neuroradiology; 2011 Oct; 53(10):779-85. PubMed ID: 21808986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very Early versus Delayed Rehabilitation for Acute Ischemic Stroke Patients with Intravenous Recombinant Tissue Plasminogen Activator: A Nationwide Retrospective Cohort Study.
    Momosaki R; Yasunaga H; Kakuda W; Matsui H; Fushimi K; Abo M
    Cerebrovasc Dis; 2016; 42(1-2):41-8. PubMed ID: 26986718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does mild deficit for patients with stroke justify the use of intravenous tissue plasminogen activator?
    Hassan AE; Zacharatos H; Hassanzadeh B; El-Gengaihy A; AlKawi A; Shhadeh A; Kirmani JF
    J Stroke Cerebrovasc Dis; 2010 Mar; 19(2):116-20. PubMed ID: 20189087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study.
    Ahmed N; Kellert L; Lees KR; Mikulik R; Tatlisumak T; Toni D;
    JAMA Neurol; 2013 Jul; 70(7):837-44. PubMed ID: 23689267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Activated Thrombin-Activatable Fibrinolysis Inhibitor Levels Following Thrombolytic Therapy in Ischemic Stroke Patients Correlate with Clinical Outcome.
    Alessi MC; Gaudin C; Grosjean P; Martin V; Timsit S; Mahagne MH; Larrue V; Sibon I; Zuber M; Brouns R; Montaner J; Castellanos M; Donazzolo Y; Cho TH; Suissa L; Mechtouff L; Derex L; Suchon P; Mezzapesa A; Nighoghossian N
    Cerebrovasc Dis; 2016; 42(5-6):404-414. PubMed ID: 27387478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten-Year Evaluation of the TOYOTA Prehospital Stroke Scale for Tissue Plasminogen Activator Intravenous Therapy in the Real World.
    Suzuki J; Nakai N; Kondo N; Tsuji H; Inagaki R; Furukawa S; Iwata M; Nishida S; Ito Y
    Cerebrovasc Dis; 2018; 46(3-4):184-192. PubMed ID: 30384371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolytic therapy for patients who wake-up with stroke.
    Barreto AD; Martin-Schild S; Hallevi H; Morales MM; Abraham AT; Gonzales NR; Illoh K; Grotta JC; Savitz SI
    Stroke; 2009 Mar; 40(3):827-32. PubMed ID: 19131657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are the results of intravenous thrombolysis trials reproduced in clinical practice? Comparison of observed and expected outcomes with the stroke-thrombolytic predictive instrument (STPI).
    Decourcelle A; Moulin S; Dequatre-Ponchelle N; Bodenant M; Rossi C; Girot M; Hénon H; Wiel E; Bordet R; Goldstein P; Pruvo JP; Cordonnier C; Leys D
    Rev Neurol (Paris); 2017 Jun; 173(6):381-387. PubMed ID: 28454980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of telemedicine on acute management of stroke patients undergoing endovascular procedures.
    Pedragosa A; Alvarez-Sabín J; Rubiera M; Rodriguez-Luna D; Maisterra O; Molina C; Brugués J; Ribó M
    Cerebrovasc Dis; 2012; 34(5-6):436-42. PubMed ID: 23207552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.